Evidence map›Paper›PMID 32127568›Full record

ArticleScientific reports2020

Immunogenicity of rat-neu

Heng Sheng Sow, Hreinn Benonisson, Conny Brouwers, Margot M Linssen, Marcel Camps, Cor Breukel, Jill Claassens, Thorbald van Hall, Ferry Ossendorp, Marieke F Fransen and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Restoring the CD226 in CD8Cell death & disease · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Heng Sheng SowDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Hreinn BenonissonDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Conny BrouwersDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Margot M LinssenDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Marcel CampsDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
Cor BreukelDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Jill ClaassensDepartment of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Thorbald van HallDepartment of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-9115-558X
Ferry OssendorpDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
Marieke F Fransen *Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
J Sjef Verbeek *Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands. j.s.verbeek@lumc.nl.
Leiden University · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of Trastuzumab (Herceptin), a monoclonal antibody (mAb) targeting HER2/neu, results in an increased median survival in Her2

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Line, TumorErb-b2 Receptor Tyrosine KinasesFemaleFlow CytometryLapatinibLeukocyte Common AntigensMaleMammary Neoplasms, AnimalMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedErb-b2 Receptor Tyrosine KinasesLapatinibLeukocyte Common AntigensneratinibpertuzumabQuinolinesTrastuzumab

Identifiers

PMID32127568
PMCPMC7054273
OpenAlexW3010163295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.